imagine if this company said that they are looking at a partnership now?
RNN would be at 2 dollars or higher if they just even hinted that they are looking at forming a partnership now.
A partnership would give even more legitimacy to what they are working on now and might eventually lead to a total buyout of this company, then a 5 dollar or higher share price.
Acknowledgement by other big pharmas by them showing keen interest is good, selling a product out to them too soon is not so good. If RNN can do their own phase III trials on say Archexin for RCC and have success, and also prove to wall street they have the ability to generate a continued pipeline, then RNN maybe the only stock you'll ever really have to have to make your retirement. t
I believe they are looking at (2) possible partnerships or (1) partnership on two compounds which was just recently noted. This may be a big surprise if this pans out to be true. See the recent article and the slide from the recent Biotech event.
Following Unmet Needs To Biotech Profits: Echo He:
"EH: I did talk to management recently. The company will probably report some data on its two phase 1 candidates during 2014, but not on the phase 2 trial for Archexin. One catalyst might be a partnership with a big pharma on the two oral compounds in phase 1. "
During the Bio Conference they said they only were looking for (1) partnership or compound, see slide 24.